- Consumer healthcare business of Pfizer Inc
Proposed acquisition of Pfizer Inc's Consumer Healthcare Business by GlaxoSmithKline plc.
Submissions are invited from interested parties regarding the proposed acquisition of Pfizer Inc's Consumer Healthcare Business by GlaxoSmithKline plc by 13 March 2019.
Submissions should be forwarded electronically (preferably in PDF format) to email@example.com with the title: “Submission re: proposed acquisition of Pfizer Inc's Consumer Healthcare Business by GlaxoSmithKline plc - attention Nigel Vise and Yong Xu.” Alternatively submissions may be mailed to the Merger Investigations Branch, ACCC, GPO Box 3131
Canberra ACT 2601.
Following 13 March 2019 queries regarding the ACCC's review may be addressed to Nigel Vise or Yong Xu at firstname.lastname@example.org. For more details, please refer to the attached market inquiries letter.
|27/02/2019||ACCC commenced informal review under the Informal Merger Review Process Guidelines.|
|13/03/2019||Closing date for submissions.|
|17/04/2019||ACCC is awaiting further information from third parties. Former provisional decision date of 25 April 2019 delayed. ACCC will announce a proposed decision date in due course.|
- Nigel Vise
- Yong Xu